⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for avutometinib

Every month we try and update this database with for avutometinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerNCT06394804
Low-Grade Serou...
Avutometinib
Defactinib
Letrozole
18 Years - Memorial Sloan Kettering Cancer Center
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous MelanomaNCT06194929
Melanoma
Defactinib
Avutometinib
Encorafenib
18 Years - University of Utah
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerNCT06394804
Low-Grade Serou...
Avutometinib
Defactinib
Letrozole
18 Years - Memorial Sloan Kettering Cancer Center
A Study of Avutometinib for People With Solid Tumor CancersNCT06104488
Refractory Canc...
CNS Tumors
CNS Tumor, Adul...
CNS Tumor, Chil...
MAP Kinase Fami...
NF1
Plexiform Neuro...
Low-grade Gliom...
Optic Pathway G...
Neuroblastoma
Primary Brain T...
Solid Tumor
Solid Tumor, Ad...
Solid Carcinoma
Central Nervous...
Avutometinib
3 Years - 30 YearsMemorial Sloan Kettering Cancer Center
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerNCT06072781
Low Grade Serou...
avutometinib
Defactinib
Pegylated lipos...
Paclitaxel
Topotecan
Letrozole
Anastrozole
18 Years - Verastem, Inc.
A Phase 2 Study of Avutometinib (VS-6766) Plus DefactinibNCT05512208
Endometrioid Ca...
Mucinous Ovaria...
High Grade Sero...
Cervical Cancer
Solid Tumor
Avutometinib (V...
18 Years - 99 YearsUniversity of Oklahoma
Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With GlioblastomaNCT05798507
Glioblastoma
Recurrent Gliob...
Avutometinib
Biospecimen Col...
Defactinib
21 Years - Emory University
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerNCT06394804
Low-Grade Serou...
Avutometinib
Defactinib
Letrozole
18 Years - Memorial Sloan Kettering Cancer Center
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal CancerNCT06369259
Advanced Colore...
Defactinib
Cetuximab
Avutometinib
18 Years - M.D. Anderson Cancer Center
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerNCT06394804
Low-Grade Serou...
Avutometinib
Defactinib
Letrozole
18 Years - Memorial Sloan Kettering Cancer Center
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous MelanomaNCT06194929
Melanoma
Defactinib
Avutometinib
Encorafenib
18 Years - University of Utah
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous MelanomaNCT06194929
Melanoma
Defactinib
Avutometinib
Encorafenib
18 Years - University of Utah
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: